Indianapolis, IN, United States of America

Michele Louise Young Bellido

This inventor holds 5 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 1999-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michele Louise Young Bellido. Retrieved from https://idiyas.com/inventor/michele-louise-young-bellido

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

5 out of 4,520

Eli Lilly and Company

patents

Years Active: 1999-2003

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. H0002071 - Streptococcus pneumoniae gene HI0454 (2003-07-01),

2. 6271000 - Streptococcus pneumoniae gene sequence mraY (2001-08-07),

3. 6171834 - Muri protein from Streptococcus pneumoniae (2001-01-09),

4. 6074847 - Streptococcus pneumoniae gene sequence HI1146 (2000-06-13),

5. 5958730 - Streptococcus pneumoniae gene sequence FtsY (1999-09-28),

Title: Michele Louise Young Bellido: Innovator in Genetic Research

Introduction

Michele Louise Young Bellido is a prominent inventor based in Indianapolis, IN (US). She has made significant contributions to the field of genetic research, holding a total of 5 patents. Her work focuses on the identification and manipulation of genetic components related to Streptococcus pneumoniae.

Latest Patents

Among her latest patents, Michele has developed isolated nucleic acid compounds encoding the 454 gene of Streptococcus pneumoniae. This invention includes vectors and transformed host cells for expressing the encoded protein, along with a method for identifying compounds that bind and/or inhibit said protein. Another notable patent involves isolated nucleic acid compounds encoding the enzyme mraY of Streptococcus pneumoniae. This invention also provides vectors and transformed host cells for expressing the encoded enzyme, as well as a method for identifying compounds that inhibit said enzyme.

Career Highlights

Michele is currently employed at Eli Lilly and Company, where she continues to advance her research in genetic engineering and biotechnology. Her innovative work has positioned her as a key figure in her field, contributing to the development of new therapeutic strategies.

Collaborations

Michele has collaborated with several esteemed colleagues, including Paul Luther Skatrud and Robert Brown Peery. These partnerships have enhanced her research efforts and expanded the impact of her inventions.

Conclusion

Michele Louise Young Bellido is a trailblazer in genetic research, with a focus on Streptococcus pneumoniae. Her contributions through her patents and collaborations reflect her dedication to advancing scientific knowledge and innovation.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]